HongKong:1443

Fulum revenue increase 12.9% in interim, Gross Profit Margin rose to 70.5%

HONG KONG, Nov. 26, 2015 /PRNewswire/ -- Financial Highlights HK$ million FY2015/6 Interim FY2014/5 Interim Change Revenue 1,308.8 1,159.1 +12.9% Restaurant operations   "Fulum" main brand 979.9 880.3 +11.3%   "Sportful Garden" main brand 166.9 167.2 -0.2%   "Fulum Concept" ma...

2015-11-26 01:25 3485

Week's Top Stories

Most Reposted

Multiple achievements made in China-Hungary BRI conference

[Picked up by 319 media titles]

2024-05-03 06:59
Multiple achievements made in China-Hungary BRI conference

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

[Picked up by 319 media titles]

2024-05-08 14:37
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

[Picked up by 318 media titles]

2024-05-07 08:00
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology

[Picked up by 310 media titles]

2024-05-08 08:00

IN2MF in Kuala Lumpur Presented by Bank Indonesia

[Picked up by 296 media titles]

2024-05-08 16:44
IN2MF in Kuala Lumpur Presented by Bank Indonesia

Most Read

/C O R R E C T I O N -- Addverb/

2024-05-03 20:26 15061
/C O R R E C T I O N -- Addverb/

Multiple achievements made in China-Hungary BRI conference

2024-05-03 06:59 10501
Multiple achievements made in China-Hungary BRI conference

Xinhua president, Hungarian economy minister vow to bolster media cooperation

2024-05-03 06:25 9876

Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

2024-05-03 14:47 6633
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

2024-05-08 18:18 5214